Description

Stenabolic SR9009 is usually grouped into the category of SARMS,
it is actually a PPAR modulator. It works by activating AMP-activated protein kinase and stimulating glucose uptake in skeletal muscle tissue. Stenabolic (SR9009) has been studied for its ability to reverse metabolic disorders and was considered as a treatment for obesity. It was shown to be very successful in this regard.
When used in clinical trials, Stenabolic (SR9009) was shown to increase the subjects resting metabolic rate, while positively influencing lipid and glucose metabolism in the liver.

SR 9009 was also shown to impact the reaction of macrophages. Macrophages are cells that eliminate dead and dying cells from the body during inflammation